对于过度活跃膀症状的男性,Mirabegron添加剂tamsulosin:对四项随机对照试验的综合分析
Yonglu Wu1, Guanjun Li1, Haimin Zhou2
1Department of Urology, Maoming People's Hospital, Maoming, China.
Urologia internationalis
|January 7, 2024
概括
将mirabegron添加到tamsulosin中显著改善了过活的膀症状 (OABS) 和生活质量. 这种组合疗法是有效的,并且耐受性很好,尽管它可能会增加空虚后的余尿量.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 过度活跃的膀症状 (OABS) 显著影响患者的整体生活质量 (QOL).
- 目前的治疗方法旨在缓解OABS,但疗效和安全性需要持续评估.
- 米拉贝格朗和坦苏洛辛是OABS管理中常用的药物.
研究的目的:
- 为了比较mirabegron作为tamsulosin附加疗法的疗效和安全性,与tamsulosin与安慰剂进行OABS治疗.
- 评估组合治疗对关键OABS参数和患者报告结果的影响.
主要方法:
- 一项对四项随机对照试验 (RCT) 的综合分析,涉及1397名OABS患者.
- 数据来源于PubMed,Embase,MEDLINE和Cochrane受控试验注册表.
- 使用审查经理5.4.4进行了元分析.
主要成果:
- 与安慰剂相比,Mirabegron补充剂tamsulosin显著降低了每日排尿频率,紧急事件和紧急尿失禁 (UUI) 事件.
- 观察到平均每次排尿量,国际前列腺症状总得分 (IPSS) 和IPSS QOL指数的显著改善.
- 虽然治疗出现的不良事件在各组之间是相似的,但mirabegron可能增加了空虚后的余尿量.
结论:
- 与mirabegron和tamsulosin的联合疗法在治疗非神经性OABS方面表现出有效性,特别是在UUI发作,总IPSS和IPSS QOL方面.
- 组合疗法似乎耐受良好,但对空余后残留尿的潜在影响需要考虑.
- 建议进行进一步的RCT来验证这些发现,并探索其他OABS因素.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
177
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
177
Cholinergic Antagonists: Pharmacokinetics
445
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
445
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
819
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
819
Open Angle Glaucoma: Treatment
453
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
453


